Your browser doesn't support javascript.
loading
Ceftriaxone dosing based on the predicted probability of augmented renal clearance in critically ill patients with pneumonia.
Dreesen, Erwin; Gijsen, Matthias; Elkayal, Omar; Annaert, Pieter; Debaveye, Yves; Wauters, Joost; Karlsson, Mats O; Spriet, Isabel.
Afiliación
  • Dreesen E; Clinical Pharmacology and Pharmacotherapy Unit, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
  • Gijsen M; Uppsala Pharmacometrics Research Group, Department of Pharmacy, Uppsala University, Uppsala, Sweden.
  • Elkayal O; Clinical Pharmacology and Pharmacotherapy Unit, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
  • Annaert P; Pharmacy Department, University Hospitals Leuven, Leuven, Belgium.
  • Debaveye Y; Clinical Pharmacology and Pharmacotherapy Unit, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
  • Wauters J; Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
  • Karlsson MO; BioNotus, Niel, Belgium.
  • Spriet I; Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium.
J Antimicrob Chemother ; 77(9): 2479-2488, 2022 08 25.
Article en En | MEDLINE | ID: mdl-35815604
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neumonía / Insuficiencia Renal Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Antimicrob Chemother Año: 2022 Tipo del documento: Article País de afiliación: Bélgica
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neumonía / Insuficiencia Renal Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Antimicrob Chemother Año: 2022 Tipo del documento: Article País de afiliación: Bélgica